Harm Reduction International publishes a summary of major debates, decisions and documents related to drug policy from the 55th session of the Human Rights Council.
C-EHRN qualitatively explore emerging local drug trends, use patterns and new psychoactive substances, within communities of high-risk drug use and communities who use drugs recreationally.
TEDI find consistent adulteration and risk trends across Europe's drug market since 2018, and call for more resources to improve market monitoring and harm reduction.
Michaud et al. analyse public discourse surrounding safer supply, highlighting potential implications of moral panic for people who use drugs and healthcare access.
EuroNPUD explore community-led communicable disease testing and care integration for people who use drugs, assessing best practice and attitudes surrounding these services.
IDPC and other organisations encourage the Special Rapporteurs to acknowledge the harmful effects of criminalising drug use and sex work in relation to the policing of people living in poverty in public spaces.
Youth RISE, SSDP International and Young Wave present a sustainability framework to develop skills, knowledge, network and strategies for young people in drug-related organisations internationally.
ICON reveals challenges faced by service users, including limited treatment options and discrimination, underscoring the need for improved support and a rights-based approach.
The BOOST project seeks to combat HIV/AIDS and viral hepatitis in Europe through community-led harm reduction initiatives, aiming to enhance health services for people who use drugs and marginalised populations.
ICEERS report analyses the legal status of ayahuasca within Portuguese drug law and argues for increased legal clarity and consistent protection from criminalisation.